Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
926
-
Total 13F shares, excl. options
-
258M
-
Shares change
-
-1.4M
-
Total reported value, excl. options
-
$22.1B
-
Value change
-
-$116M
-
Put/Call ratio
-
0.61
-
Number of buys
-
399
-
Number of sells
-
-375
-
Price
-
$85.85
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q3 2017
999 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q3 2017.
NOVARTIS AG - Ordinary Shares (NVS) has 926 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 258M shares
of 2.18B outstanding shares and own 11.82% of the company stock.
Largest 10 shareholders include DODGE & COX (44.6M shares), PRIMECAP MANAGEMENT CO/CA/ (22M shares), FRANKLIN RESOURCES INC (15.5M shares), BROWN BROTHERS HARRIMAN & CO (10.1M shares), PARNASSUS INVESTMENTS /CA (9.45M shares), BANK OF AMERICA CORP /DE/ (8.74M shares), WELLS FARGO & COMPANY/MN (7.87M shares), LOOMIS SAYLES & CO L P (6.8M shares), Fisher Asset Management, LLC (6.63M shares), and UBS Group AG (6.15M shares).
This table shows the top 926 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.